Rezolute, Inc. (RZLT) stock
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
$4.25+0.24 (+5.85%)
Close on Nov 18, 2026Market cap $411.07MP/E –Yield –
Rezolute total assets
Total assets on the balance sheet at the end of each period.
Rezolute's total assets was $96.01M at Sep 30, 2026. For fiscal 2026 it was $112.85M, down 35.7% from the year before. Over ten years it grew 26.3% a year on average. The highest annual figure on record is $175.49M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $112.85M | -35.7% |
| FY2025 | Jun 30, 2025 | $175.49M | +32.2% |
| FY2024 | Jun 30, 2024 | $132.74M | +7.3% |
| FY2023 | Jun 30, 2023 | $123.72M | -18.8% |
| FY2022 | Jun 30, 2022 | $152.42M | +257.7% |
| FY2021 | Jun 30, 2021 | $42.61M | +288.6% |
| FY2020 | Jun 30, 2020 | $10.97M | -10.5% |
| FY2019 | Jun 30, 2019 | $12.25M | +389.5% |
| FY2018 | Jun 30, 2018 | $2.50M | -76.5% |
| FY2017 | Jun 30, 2017 | $10.63M | -2.5% |
| FY2016 | Jun 30, 2016 | $10.90M | -3.2% |
| FY2015 | Jun 30, 2015 | $11.26M | +52.1% |
| FY2014 | Jun 30, 2014 | $7.40M | +1208.7% |
| FY2011 | Dec 31, 2011 | $565.79K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $96.01M | -39.5% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $112.85M | -35.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $125.46M | +32.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $138.63M | +23.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $158.66M | +28.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $175.49M | +32.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $94.74M | +8.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $112.01M | +9.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $123.41M | +9.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $132.74M | +7.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $87.74M | -34.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $102.15M | -32.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $113.00M | -27.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $123.72M | -18.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $134.21M | +92.9% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $150.21M | +80.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $155.99M | +302.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $152.42M | +257.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $69.57M | +111.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $83.41M | +114.4% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $38.76M | +423.1% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $42.61M | +288.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $32.93M | +124.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $38.90M | +89.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $7.41M | -72.1% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $10.97M | -10.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $14.70M | +487.3% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $20.57M | +300.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $26.57M | +320.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $12.25M | +25.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $2.50M | -76.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $5.14M | -52.4% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $6.32M | -36.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $9.80M | -2.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $10.63M | -2.5% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $10.80M | +22.8% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $9.94M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $10.06M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $10.90M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $8.79M | – |
See a number that looks wrong?